These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3714913)

  • 21. [Dexamethasone suppression test and suicide].
    Van Wettere JP; Charles G; Wilmotte J
    Acta Psychiatr Belg; 1983; 83(6):569-78. PubMed ID: 6673520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suicidal behavior and hypothalamic-pituitary-adrenocortical axis indices in child psychiatric inpatients.
    Pfeffer CR; Stokes P; Shindledecker R
    Biol Psychiatry; 1991 May; 29(9):909-17. PubMed ID: 2049489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A longitudinal evaluation of dexamethasone and cortisol plasma concentrations in the dexamethasone suppression test before and during treatment with antidepressant drugs.
    Guthrie SK; Vartanian L; Grunhaus L; Hariharan M; Pande A; Haskett RF
    Acta Psychiatr Scand; 1990 Dec; 82(6):427-32. PubMed ID: 2291411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delusional depression, family history, and DST response: a pilot study.
    Bond TC; Rothschild AJ; Lerbinger J; Schatzberg AF
    Biol Psychiatry; 1986 Nov; 21(13):1239-46. PubMed ID: 3756274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose (0.5-mg) dexamethasone suppression test in depressive patients.
    Sarai M; Matsunaga H
    Biol Psychiatry; 1986 Jul; 21(8-9):744-50. PubMed ID: 3730459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depressive behavior and hyperactive adrenocortical function.
    Kocsis JH; Davis JM; Katz MM; Koslow SH; Stokes PE; Casper R; Redmond DE
    Am J Psychiatry; 1985 Nov; 142(11):1291-8. PubMed ID: 4061688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological correlations of suicide and aggressivity in major depressions (with melancholia): 5-hydroxyindoleacetic acid and cortisol in cerebral spinal fluid, dexamethasone suppression test and therapeutic response to 5-hydroxytryptophan.
    López-Ibor JJ; Saiz-Ruiz J; Pérez de los Cobos JC
    Neuropsychobiology; 1985; 14(2):67-74. PubMed ID: 2418384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects.
    Carson SW; Halbreich U; Yeh CM; Asnis G; Goldstein S
    Biol Psychiatry; 1988 Sep; 24(5):569-77. PubMed ID: 3167145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dexamethasone suppression test in affective illnesses and schizophrenia: relationship with psychotic symptoms.
    Hubain PP; Simonnet MP; Mendlewicz J
    Neuropsychobiology; 1986; 16(2-3):57-60. PubMed ID: 3587576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HPA axis hyperactivity and attempted suicide in young adult mood disorder inpatients.
    Jokinen J; Nordström P
    J Affect Disord; 2009 Jul; 116(1-2):117-20. PubMed ID: 19054569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mean 14.00-17.00 h plasma cortisol concentration and its relationship to the 1 mg-dexamethasone suppression response in depressives and controls.
    Holsboer F; Gerken A; Steiger A; Fass V
    Acta Psychiatr Scand; 1984 May; 69(5):383-90. PubMed ID: 6730994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dexamethasone suppression test as a biologic marker of depression in chronic pain.
    France RD; Krishnan RRK
    Pain; 1985 Jan; 21(1):49-55. PubMed ID: 3157090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPA axis dysregulation in men with hypersexual disorder.
    Chatzittofis A; Arver S; Öberg K; Hallberg J; Nordström P; Jokinen J
    Psychoneuroendocrinology; 2016 Jan; 63():247-53. PubMed ID: 26519779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dexamethasone suppression test and suicide attempts.
    Schmidtke A; Fleckenstein P; Beckmann H
    Acta Psychiatr Scand; 1989 Mar; 79(3):276-82. PubMed ID: 2711855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DST studies in psychotic depression: a meta-analysis.
    Nelson JC; Davis JM
    Am J Psychiatry; 1997 Nov; 154(11):1497-503. PubMed ID: 9356556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome.
    Beck-Friis J; Kjellman BF; Aperia B; Undén F; von Rosen D; Ljunggren JG; Wetterberg L
    Acta Psychiatr Scand; 1985 Apr; 71(4):319-30. PubMed ID: 4039876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CSF 5-HIAA and DST non-suppression -independent biomarkers in suicide attempters?
    Jokinen J; Mårtensson B; Nordström AL; Nordström P
    J Affect Disord; 2008 Jan; 105(1-3):241-5. PubMed ID: 17499856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adrenocorticotropin and cortisol response to lysine vasopressin in relation to the outcome of the dexamethasone suppression test in major depressive disorder.
    Akner G; Ljunggren JG; Kjellman BF; Undén F; Wetterberg L
    Acta Psychiatr Scand; 1988 Apr; 77(4):404-10. PubMed ID: 2839010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined dexamethasone suppression-corticotropin-releasing hormone stimulation test in studies of depression, alcoholism, and suicidal behavior.
    Sher L
    ScientificWorldJournal; 2006 Oct; 6():1398-404. PubMed ID: 17086345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dexamethasone suppression test findings in subjects with personality disorders: associations with posttraumatic stress disorder and major depression.
    Grossman R; Yehuda R; New A; Schmeidler J; Silverman J; Mitropoulou V; Sta Maria N; Golier J; Siever L
    Am J Psychiatry; 2003 Jul; 160(7):1291-8. PubMed ID: 12832244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.